9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Whole-genome sequencing allows rapid detection of drug-resistant Mycobacterium tuberculosis isolates. However, the availability of high-quality data linking quantitative phenotypic drug susceptibility testing (DST) and genomic data have thus far been limited.

          ABSTRACT

          Whole-genome sequencing allows rapid detection of drug-resistant Mycobacterium tuberculosis isolates. However, the availability of high-quality data linking quantitative phenotypic drug susceptibility testing (DST) and genomic data have thus far been limited. We determined drug resistance profiles of 176 genetically diverse clinical M. tuberculosis isolates from the Democratic Republic of the Congo, Ivory Coast, Peru, Thailand, and Switzerland by quantitative phenotypic DST for 11 antituberculous drugs using the BD Bactec MGIT 960 system and 7H10 agar dilution to generate a cross-validated phenotypic DST readout. We compared DST results with predicted drug resistance profiles inferred by whole-genome sequencing. Classification of strains by the two phenotypic DST methods into resistotype/wild-type populations was concordant in 73 to 99% of cases, depending on the drug. Our data suggest that the established critical concentration (5 mg/liter) for ethambutol resistance (MGIT 960 system) is too high and misclassifies strains as susceptible, unlike 7H10 agar dilution. Increased minimal inhibitory concentrations were explained by mutations identified by whole-genome sequencing. Using whole-genome sequences, we were able to predict quantitative drug resistance levels for the majority of drug resistance mutations. Predicting quantitative levels of drug resistance by whole-genome sequencing was partially limited due to incompletely understood drug resistance mechanisms. The overall sensitivity and specificity of whole-genome-based DST were 86.8% and 94.5%, respectively. Despite some limitations, whole-genome sequencing has the potential to infer resistance profiles without the need for time-consuming phenotypic methods.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          DNA Sequencing Predicts 1st-Line Tuberculosis Drug Susceptibility Profiles

          Background The World Health Organization recommends universal drug susceptibility testing for Mycobacterium tuberculosis complex to guide treatment decisions and improve outcomes. We assessed whether DNA sequencing can accurately predict antibiotic susceptibility profiles for first-line anti-tuberculosis drugs. Methods Whole-genome sequences and associated phenotypes to isoniazid, rifampicin, ethambutol and pyrazinamide were obtained for isolates from 16 countries across six continents. For each isolate, mutations associated with drug-resistance and drug-susceptibility were identified across nine genes, and individual phenotypes were predicted unless mutations of unknown association were also present. To identify how whole-genome sequencing might direct first-line drug therapy, complete susceptibility profiles were predicted. These were predicted to be pan-susceptible if predicted susceptible to isoniazid and to other drugs, or contained mutations of unknown association in genes affecting these other drugs. We simulated how negative predictive value changed with drug-resistance prevalence. Results 10,209 isolates were analysed. The greatest proportion of phenotypes were predicted for rifampicin (9,660/10,130; (95.4%)) and the lowest for ethambutol (8,794/9,794; (89.8%)). Isoniazid, rifampicin, ethambutol and pyrazinamide resistance was correctly predicted with 97.1%, 97.5% 94.6% and 91.3% sensitivity, and susceptibility with 99.0%, 98.8%, 93.6% and 96.8% specificity, respectively. 5,250 (89.5%) drug profiles were correctly predicted for 5,865/7,516 (78.0%) isolates with complete phenotypic profiles. Among these, 3,952/4,037 (97.9%) predictions of pan-susceptibility were correct. The negative predictive value for 97.5% of simulated drug profiles exceeded 95% where the prevalence of drug-resistance was below 47.0%. Conclusions Phenotypic testing for first-line drugs can be phased down in favour of DNA sequencing to guide anti- tuberculosis drug therapy.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Streptomycin, a Substance Exhibiting Antibiotic Activity Against Gram-Positive and Gram-Negative Bacteria.* 

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.

              Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.
                Bookmark

                Author and article information

                Journal
                Antimicrob Agents Chemother
                Antimicrob. Agents Chemother
                aac
                aac
                AAC
                Antimicrobial Agents and Chemotherapy
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                0066-4804
                1098-6596
                4 February 2019
                27 March 2019
                April 2019
                27 March 2019
                : 63
                : 4
                : e02175-18
                Affiliations
                [a ]Swiss Tropical and Public Health Institute, Basel, Switzerland
                [b ]University of Basel, Basel, Switzerland
                [c ]Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland
                [d ]National Center for Mycobacteria, University of Zürich, Zürich, Switzerland
                [e ]Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
                [f ]HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand
                [g ]TB Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
                [h ]Centre de Prise en Charge de Recherche et de Formation, Yopougon, Abidjan, Côte d'Ivoire
                [i ]College of Public Health, Ohio State University, Columbus, Ohio, USA
                [j ]Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa
                [k ]Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
                [l ]Institute for Infectious Diseases, University of Bern, Bern, Switzerland
                Author notes
                Address correspondence to Sebastien Gagneux, sebastien.gagneux@ 123456swisstph.ch , or Erik C. Böttger, boettger@ 123456imm.uzh.ch .

                S.M.G. and P.M.K. are co-first authors, and M.E., S.G., and E.C.B. are co-last authors.

                Citation Gygli SM, Keller PM, Ballif M, Blöchliger N, Hömke R, Reinhard M, Loiseau C, Ritter C, Sander P, Borrell S, Collantes Loo J, Avihingsanon A, Gnokoro J, Yotebieng M, Egger M, Gagneux S, Böttger EC. 2019. Whole-genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis. Antimicrob Agents Chemother 63:e02175-18. https://doi.org/10.1128/AAC.02175-18.

                Article
                02175-18
                10.1128/AAC.02175-18
                6496161
                30718257
                8946df4f-3cc0-4516-be3e-25583bbb8c23
                Copyright © 2019 Gygli et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 15 October 2018
                : 21 November 2018
                : 25 January 2019
                Page count
                supplementary-material: 2, Figures: 4, Tables: 4, Equations: 0, References: 49, Pages: 13, Words: 7860
                Funding
                Funded by: European Research Council (ERC);
                Award ID: 309540-EVODRTB
                Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient :
                Funded by: SystemsX.ch;
                Award ID: TbX
                Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient :
                Funded by: HHS | National Institutes of Health (NIH), https://doi.org/10.13039/100000002;
                Award ID: U01 AI096299
                Award ID: U01 AI069919
                Award ID: U01 AI069924
                Award ID: U01 AI069911
                Award ID: U01 AI069907
                Award ID: U01 AI096186
                Award ID: U01 AI069923
                Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient :
                Funded by: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (FNS), https://doi.org/10.13039/501100001711;
                Award ID: IZRJZ3_164171
                Award ID: 310030-166687
                Award ID: IZLSZ3_170834
                Award ID: CRSII5_177163
                Award ID: 31003A_153349
                Award ID: 320030_153442/1
                Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient : Award Recipient :
                Categories
                Mechanisms of Resistance
                Custom metadata
                April 2019

                Infectious disease & Microbiology
                drug resistance,drug resistance level prediction,mycobacterium tuberculosis,quantitative phenotypic drug susceptibility testing,whole-genome sequencing

                Comments

                Comment on this article